読み込み中…
ここに並ぶすべての企業が、同じ 5 つの成長・現金創出チェックを受けています。これは業種が今日報告している姿の説明であって、どれを買うべきかではありません。
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | $136.5B | $538.53 | 34.68 | $13B | 30.7% |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | $100.9B | $955.80 | 21.10 | $16.9B | 28.5% |
| MRNA | Moderna, Inc. | C- | $90.3B | $223.22 | — | $2.5B | -110.5% |
| ARGX | ARGENX SE | 評価なし | $59.4B | $959.78 | 49.04 | — | — |
| ONC | BEONE MEDICINES LTD. | A+ | $47.6B | $416.41 | 53.39 | $6.6B | 13.9% |
| RPRX | Royalty Pharma plc | C+ | $39.8B | $69.30 | 45.29 | $2.6B | 25.7% |
| RVMD | Revolution Medicines, Inc. | F | $37.3B | $172.27 | — | $0.00 | — |
| ROIV | ROIVANT SCIENCES LTD. | B- | $28.6B | $39.54 | — | $41.1M | -838.2% |
| INSM | INSMED INC | C- | $26.6B | $121.15 | — | $1.5B | -39.9% |
| INCY | INCYTE CORPORATION | C | $24.7B | $120.94 | 64.33 | $6B | 6.7% |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | B+ | $22.1B | $165.05 | 70.84 | $3.7B | 71.3% |
| BNTX | BioNTech SE | F | $21.5B | $85.57 | — | $2.7B | -60.9% |
| NCNA | NUCANA PLC | 評価なし | $18.5B | $0.89 | — | — | — |
| ASND | Ascendis Pharma A/S | D | $17.1B | $275.33 | — | $1.3B | -19.0% |
| EXEL | EXELIXIS, INC. | A+ | $16.8B | $68.99 | 20.66 | $2.5B | 35.5% |
| JAZZ | Jazz Pharmaceuticals plc | A | $15.5B | $241.38 | 78.63 | $4.7B | 4.4% |
| BBIO | BridgeBio Pharma, Inc. | B | $15.3B | $78.31 | — | $945.5M | -60.7% |
| AKTX | Akari Therapeutics, Plc | 評価なし | $12.7B | $6.85 | — | — | — |
| TECH | BIO-TECHNE Corp | A+ | $11.4B | $72.80 | 66.79 | $1.2B | 14.0% |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | $11.4B | $100.30 | 25.01 | $1.8B | 26.9% |
| SMMT | Summit Therapeutics Inc. | 評価なし | $11.3B | $14.14 | — | — | — |
| BMRN | BioMarin Pharmaceutical Inc | B | $11.1B | $57.22 | — | $3.7B | -0.5% |
| KYMR | KYMERA THERAPEUTICS, INC. | F- | $10.9B | $127.63 | — | $102.2M | -341.8% |
| PCVX | VAXCYTE, INC. | 評価なし | $10B | $63.36 | — | — | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | B- | $9.9B | $427.50 | — | $1.4B | -10.9% |
| SYRE | SPYRE THERAPEUTICS, INC. | D | $9.9B | $104.01 | — | $0.00 | — |
| TGTX | TG THERAPEUTICS, INC. | A+ | $9.7B | $64.49 | 96.25 | $897.8M | 11.8% |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | $9.2B | $327.93 | — | $0.00 | — |
| KRYS | Krystal Biotech, Inc. | A+ | $9B | $304.96 | 41.38 | $470M | 47.9% |
| PTGX | PROTAGONIST THERAPEUTICS, INC. | A+ | $8.5B | $130.83 | 27.78 | $551.7M | 62.0% |
| CORT | CORCEPT THERAPEUTICS INC | A+ | $8B | $72.94 | 57.43 | $963.6M | 16.8% |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | $8B | $115.03 | — | $280.7M | -69.0% |
| CYTK | CYTOKINETICS, INCORPORATED | D | $7.8B | $56.14 | — | $113.3M | -686.6% |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | $7.4B | $141.54 | — | $865.3M | -18.2% |
| KOD | KODIAK SCIENCES INC. | 評価なし | $7.3B | $111.19 | — | — | — |
| ORKA | Oruka Therapeutics, Inc. | 評価なし | $7.1B | $105.34 | — | — | — |
| IMVT | Immunovant, Inc. | 評価なし | $7.1B | $34.19 | — | — | — |
| TWST | Twist Bioscience Corporation | C- | $7B | $111.56 | — | $459.4M | -28.3% |
| ABVX | Abivax S.A. | 評価なし | $6.9B | $87.63 | — | — | — |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | F- | $6.8B | $47.77 | — | $450.8M | -160.6% |
| CGON | CG Oncology, Inc. | F- | $6.6B | $74.35 | — | $6.2M | -3,851.1% |
| CAI | CARIS LIFE SCIENCES, INC. | A | $6.6B | $23.05 | 13.89 | $1B | 9.2% |
| BLTE | Belite Bio, Inc | 評価なし | $6.5B | $164.03 | — | — | — |
| IBRX | IMMUNITYBIO, INC. | C | $6.4B | $6.01 | — | $182.6M | -607.8% |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | C | $6.2B | $309.05 | 134.37 | $253.8M | 20.3% |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | $6.1B | $94.00 | — | $670.8M | -134.8% |
| ERAS | ERASCA, INC. | 評価なし | $5.5B | $15.65 | — | — | — |
| MANE | Veradermics, Inc | 評価なし | $5.5B | $129.60 | — | — | — |
| PTCT | PTC Therapeutics, Inc. | D | $5.3B | $63.49 | — | $1.2B | -9.2% |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F- | $5.3B | $43.16 | — | $570K | -72,563.2% |
| DNTH | Dianthus Therapeutics, Inc. | F- | $5.2B | $91.76 | — | $2M | -9,927.5% |
| EWTX | Edgewise Therapeutics, Inc. | 評価なし | $5B | $45.97 | 5.62 | — | — |
| COGT | Cogent Biosciences, Inc. | 評価なし | $5B | $28.53 | — | — | — |
| TVTX | TRAVERE THERAPEUTICS, INC. | F- | $4.9B | $50.63 | — | $651M | -18.7% |
| IONS | IONIS PHARMACEUTICALS, INC. | F- | $4.8B | $29.06 | — | $960.1M | -56.9% |
| DFTX | Definium Therapeutics, Inc. | 評価なし | $4.4B | $32.09 | — | — | — |
| TNGX | TANGO THERAPEUTICS, INC. | F | $4.3B | $25.52 | — | $0.00 | — |
| GPCR | Structure Therapeutics Inc. | 評価なし | $4.3B | $20.01 | — | — | — |
| CRSP | CRISPR THERAPEUTICS AG | F- | $4.1B | $42.21 | — | $25.2M | -1,812.1% |
| ZLAB | ZAI LAB LIMITED | F- | $4B | $24.61 | — | $441.7M | -44.9% |
| RLAY | RELAY THERAPEUTICS, INC. | D- | $4B | $18.10 | — | $10.4M | -2,837.0% |
| XENE | Xenon Pharmaceuticals Inc. | F | $4B | $40.49 | — | $0.00 | — |
| TARS | TARSUS PHARMACEUTICALS, INC. | B- | $4B | $80.25 | — | $682.2M | -102.9% |
| ABCL | AbCellera Biologics Inc. | C- | $3.8B | $11.49 | — | $67.9M | -218.5% |
| VKTX | VIKING THERAPEUTICS, INC. | F | $3.7B | $29.25 | — | $0.00 | — |
| IRON | Disc Medicine, Inc. | 評価なし | $3.6B | $80.00 | — | — | — |
| ELVN | ENLIVEN THERAPEUTICS, INC. | 評価なし | $3.6B | $48.77 | — | — | — |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | $3.6B | $7.75 | — | $379M | -58.2% |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | B | $3.6B | $28.25 | 134.52 | $508.7M | 5.9% |
| PBLS | Parabilis Medicines, Inc. | 評価なし | $3.6B | $28.44 | — | — | — |
| VRDN | Viridian Therapeutics, Inc./DE | F- | $3.5B | $30.86 | — | $26.3M | -1,724.1% |
| DBVT | DBV TECHNOLOGIES S.A. | F- | $3.5B | $11.07 | — | $3.8M | -5,405.3% |
| ACAD | ACADIA PHARMACEUTICALS INC. | B+ | $3.2B | $18.73 | 8.83 | $1.2B | 30.1% |
| LEGN | Legend Biotech Corp | C- | $3.2B | $17.49 | — | $1.1B | -22.0% |
| GMAB | Genmab A/S | B+ | $3.2B | $51.36 | 3.34 | $3.9B | 21.0% |
| DYN | Dyne Therapeutics, Inc. | 評価なし | $3.2B | $17.17 | — | — | — |
| CELC | CELCUITY INC. | 評価なし | $3.2B | $64.32 | — | — | — |
| TLX | Telix Pharmaceuticals Limited | D | $3.1B | $9.23 | — | $890.8M | 3.8% |
| IDYA | IDEAYA Biosciences, Inc. | F- | $3.1B | $31.82 | — | $36.5M | -1,149.6% |
| ADMA | ADMA BIOLOGICS, INC. | B+ | $3B | $13.69 | 17.78 | $519.2M | 35.1% |
| DNLI | Denali Therapeutics Inc. | F | $3B | $18.74 | — | $0.00 | — |
| VCEL | VERICEL CORPORATION | A | $2.9B | $56.96 | 89.00 | $324.2M | 10.3% |
| XNCR | Xencor, Inc | D- | $2.8B | $37.08 | — | $200.5M | -58.8% |
| MBX | MBX Biosciences, Inc. | 評価なし | $2.8B | $55.98 | — | — | — |
| RCUS | Arcus Biosciences, Inc. | F- | $2.5B | $17.43 | — | $100M | -453.0% |
| NAMS | NewAmsterdam Pharma Company N.V. | D- | $2.4B | $20.16 | — | $25.9M | -789.9% |
| BEAM | Beam Therapeutics Inc. | F- | $2.4B | $22.82 | — | $146.6M | -73.9% |
| CLDX | Celldex Therapeutics, Inc. | F- | $2.3B | $28.82 | — | $158K | -195,608.9% |
| LKFT | GALAPAGOS NV | D | $2.2B | $33.95 | 6.31 | $1.2B | 28.9% |
| PVLA | Palvella Therapeutics, Inc. | 評価なし | $2.2B | $152.51 | — | — | — |
| IMNM | Immunome Inc. | F | $2.2B | $18.74 | — | $0.00 | — |
| PHVS | Pharvaris N.V. | 評価なし | $2.2B | $33.37 | — | — | — |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | $2.1B | $15.73 | 6.87 | $321.7M | 97.7% |
| BHVN | Biohaven Ltd. | 評価なし | $2.1B | $13.81 | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | 評価なし | $2.1B | $21.90 | — | — | — |
| VERA | Vera Therapeutics, Inc. | 評価なし | $2B | $28.11 | — | — | — |
| SEPN | Septerna, Inc. | F- | $2B | $42.61 | — | $96.3M | -61.3% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | B+ | $2B | $33.76 | 11.14 | $989.4M | 18.1% |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | 評価なし | $2B | $47.15 | — | — | — |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | $2B | $3.18 | — | $68.2M | -697.1% |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | $2B | $7.54 | — | $213M | -30.8% |
| FTRE | Fortrea Holdings Inc. | C | $1.9B | $20.20 | — | $2.7B | -2.6% |
| TRVI | TREVI THERAPEUTICS, INC. | 評価なし | $1.9B | $13.65 | — | — | — |
| COAG | Hemab Therapeutics Holdings, Inc. | 評価なし | $1.9B | $40.79 | — | — | — |
| ZBIO | Zenas BioPharma, Inc. | F- | $1.9B | $27.99 | — | $10M | -5,418.1% |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | $1.9B | $31.57 | — | $140.8M | -264.8% |
| MAZE | MAZE THERAPEUTICS, INC. | 評価なし | $1.9B | $34.29 | — | — | — |
| ZYME | ZYMEWORKS INC. | F+ | $1.8B | $26.24 | 50.46 | $266M | 16.3% |
| BRVE | Braveheart Bio, Inc. | 評価なし | $1.8B | $19.67 | — | — | — |
| STOK | Stoke Therapeutics, Inc. | F- | $1.7B | $26.66 | — | $28.2M | -862.1% |
| SRPT | SAREPTA THERAPEUTICS, INC. | C | $1.7B | $16.07 | — | $2B | -5.9% |
| KLRA | Kailera Therapeutics, Inc. | 評価なし | $1.7B | $13.26 | — | — | — |
| MESO | MESOBLAST LIMITED | C- | $1.7B | $13.25 | — | $65.4M | -144.3% |
| VIR | Vir Biotechnology, Inc. | C- | $1.7B | $9.96 | — | $302.8M | -61.0% |
| NRIX | NURIX THERAPEUTICS, INC. | A+ | $1.7B | $15.47 | 6.72 | $701.9M | 42.0% |
| QURE | uniQure N.V. | F- | $1.7B | $23.84 | — | $20.2M | -1,154.8% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | $1.6B | $16.07 | — | $730M | -71.8% |
| PGEN | PRECIGEN, INC. | C | $1.6B | $4.52 | 45.20 | $156.9M | 15.6% |
| SLS | SELLAS Life Sciences Group, Inc. | 評価なし | $1.6B | $7.87 | — | — | — |
| GENB | Generate Biomedicines, Inc. | 評価なし | $1.6B | $12.06 | — | — | — |
| RAPP | Rapport Therapeutics, Inc. | 評価なし | $1.6B | $26.16 | — | — | — |
| IMCR | Immunocore Holdings plc | F- | $1.5B | $29.99 | — | $429.3M | -7.5% |
| NBTX | Nanobiotix S.A. | C- | $1.5B | $30.34 | — | $36.4M | -73.5% |
| ABSI | ABSCI CORP | F- | $1.5B | $8.45 | — | $1.5M | -8,451.3% |
| NUVB | Nuvation Bio Inc. | C- | $1.4B | $3.99 | — | $201.7M | -67.4% |
| NVAX | NOVAVAX, INC. | F | $1.4B | $8.53 | — | $411.6M | -18.6% |
| LBRX | LB Pharmaceuticals Inc | 評価なし | $1.4B | $42.93 | — | — | — |
| TYRA | TYRA BIOSCIENCES, INC. | 評価なし | $1.4B | $20.03 | — | — | — |
| ANAB | ANAPTYSBIO, INC. | D+ | $1.4B | $46.26 | 8.68 | $191.6M | 96.3% |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | D- | $1.4B | $14.71 | — | $96.6M | -193.4% |
| OCUL | OCULAR THERAPEUTIX, INC | F- | $1.4B | $6.20 | — | $50.4M | -648.6% |
| NTLA | INTELLIA THERAPEUTICS, INC. | D- | $1.4B | $9.70 | — | $52.9M | -805.7% |
| MLYS | MINERALYS THERAPEUTICS, INC. | 評価なし | $1.4B | $15.32 | — | — | — |
| INVA | INNOVIVA, INC. | C+ | $1.4B | $19.03 | 9.51 | $438.3M | 44.1% |
| AVLN | Avalyn Pharma Inc. | 評価なし | $1.3B | $30.26 | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | 評価なし | $1.3B | $21.61 | — | — | — |
| TSHA | Taysha Gene Therapies, Inc. | F- | $1.3B | $4.09 | — | $5.5M | -2,844.6% |
| MNKD | MannKind Corporation | D | $1.3B | $4.12 | — | $413.4M | -18.1% |
| KARD | Kardigan, Inc. | 評価なし | $1.3B | $13.83 | — | — | — |
| URGN | UroGen Pharma Ltd. | C | $1.3B | $26.18 | — | $250.3M | -26.3% |
| NKTR | NEKTAR THERAPEUTICS | F- | $1.3B | $37.29 | — | $52.2M | -339.7% |
| OMER | OMEROS CORP | 評価なし | $1.3B | $17.49 | 10.17 | — | — |
| SLN | Silence Therapeutics plc | F- | $1.2B | $19.84 | — | $456K | -11,276.5% |
| INBX | Inhibrx Biosciences, Inc. | D- | $1.2B | $83.17 | — | $1.3M | -10,896.8% |
| VOR | Vor Biopharma Inc. | 評価なし | $1.2B | $19.42 | 0.06 | — | — |
| ANRO | Alto Neuroscience, Inc. | 評価なし | $1.2B | $29.66 | — | — | — |
| GHRS | GH Research PLC | 評価なし | $1.2B | $19.17 | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | 評価なし | $1.2B | $13.37 | — | — | — |
| JBIO | Jade Biosciences, Inc. | 評価なし | $1.1B | $16.13 | — | — | — |
| SGP | SpyGlass Pharma, Inc. | 評価なし | $1.1B | $32.93 | — | — | — |
| SPTX | Seaport Therapeutics, Inc. | 評価なし | $1.1B | $19.93 | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 評価なし | $1.1B | $12.51 | — | — | — |
| VSTM | Verastem, Inc. | F- | $1B | $8.19 | — | $100.3M | -178.4% |
| SVRA | Savara Inc. | 評価なし | $1B | $4.64 | — | — | — |
| AKTS | Aktis Oncology, Inc. | 評価なし | $928.5M | $16.64 | — | — | — |
| ODTX | Odyssey Therapeutics, Inc. | 評価なし | $918.1M | $19.10 | — | — | — |
| PHAR | Pharming Group N.V. | A | $912.9M | $13.01 | 325.25 | $376.1M | 0.8% |
| MGTX | MeiraGTx Holdings plc | B | $898.6M | $9.20 | 11.49 | $401.9M | 19.5% |
| CRVS | Corvus Pharmaceuticals, Inc. | 評価なし | $896.7M | $10.63 | — | — | — |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | $884.5M | $12.22 | — | $96.1M | -208.6% |
| LTGO | Latigo Biotherapeutics, Inc. | 評価なし | $872.2M | $13.16 | — | — | — |
| IMTX | Immatics N.V. | 評価なし | $857.4M | $6.40 | — | — | — |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | $843M | $9.44 | — | $289.7M | -72.3% |
| RIGL | RIGEL PHARMACEUTICALS INC | B+ | $838.9M | $44.55 | 2.77 | $288.2M | 106.6% |
| ORIC | ORIC PHARMACEUTICALS, INC. | 評価なし | $811.6M | $7.83 | — | — | — |
| ANNX | ANNEXON, INC. | 評価なし | $807.7M | $3.93 | — | — | — |
| LXRX | Lexicon Pharmaceuticals, Inc. | D- | $801.4M | $1.80 | — | $38.5M | -161.8% |
| GLUE | Monte Rosa Therapeutics, Inc. | F- | $800.7M | $9.37 | — | $70.3M | -186.2% |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | $777.1M | $12.58 | — | $0.00 | — |
| ARDX | ARDELYX, INC. | C- | $774.2M | $3.08 | — | $468.2M | -11.8% |
| PRME | Prime Medicine, Inc. | B- | $774.1M | $4.26 | — | $4.6M | -3,807.3% |
| SLDB | Solid Biosciences Inc. | 評価なし | $763.4M | $6.84 | — | — | — |
| ACHV | Achieve Life Sciences, Inc. | 評価なし | $747.1M | $6.79 | — | — | — |
| AURA | AURA BIOSCIENCES, INC. | 評価なし | $740M | $7.11 | — | — | — |
| SGMT | Sagimet Biosciences Inc. | 評価なし | $729.4M | $10.22 | — | — | — |
| ALMS | Alumis Inc. | F- | $725.7M | $5.59 | — | $7.2M | -5,844.5% |
| OABI | OMNIAB, INC. | B | $715.4M | $4.91 | — | $40.2M | -108.1% |
| KURA | Kura Oncology, Inc. | C- | $713.4M | $7.77 | — | $79.3M | -369.3% |
| IVA | Inventiva S.A. | F | $711.1M | $3.68 | — | $5M | -7,899.6% |
| APMD | Apnimed, Inc. | 評価なし | $705.4M | $16.95 | — | — | — |
| NVCT | NUVECTIS PHARMA, INC. | 評価なし | $697.4M | $20.28 | — | — | — |
| JANX | Janux Therapeutics, Inc. | C- | $695M | $11.36 | — | $23.3M | -428.7% |
| ATTO | Attovia Therapeutics, Inc. | 評価なし | $693.9M | $15.18 | — | — | — |
| AVBP | ARRIVENT BIOPHARMA, INC. | 評価なし | $673.4M | $13.02 | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | $670.8M | $10.48 | — | $0.00 | — |
| CGEM | CULLINAN THERAPEUTICS, INC. | 評価なし | $667.1M | $10.28 | — | — | — |
| BCAX | BICARA THERAPEUTICS INC. | 評価なし | $665.9M | $10.03 | — | — | — |
| OLMA | OLEMA PHARMACEUTICALS, INC. | 評価なし | $660.6M | $7.54 | — | — | — |
| IMMX | IMMIX BIOPHARMA, INC. | 評価なし | $656.3M | $7.83 | — | — | — |
| ABUS | ARBUTUS BIOPHARMA CORP | D+ | $627M | $4.09 | 3.62 | $181.5M | 121.2% |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | F- | $623M | $9.61 | — | $130.8M | -192.0% |
| ACRS | Aclaris Therapeutics, Inc. | F- | $621.8M | $3.92 | — | $6.4M | -1,244.1% |
| GERN | GERON CORP | 評価なし | $618.5M | $0.96 | — | — | — |
| WVE | WAVE LIFE SCIENCES, INC. | F- | $618.3M | $3.14 | — | $70.9M | -296.9% |
| CLYM | Climb Bio, Inc. | 評価なし | $607.9M | $10.35 | — | — | — |
| SANA | Sana Biotechnology, Inc. | 評価なし | $603.8M | $2.02 | — | — | — |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | $569M | $7.23 | — | $31.2M | -182.5% |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | $553.8M | $9.53 | — | $0.00 | — |
| CBIO | Crescent Biopharma, Inc. | D- | $553.5M | $14.23 | — | $15M | -727.6% |
| ENTX | ENTERA BIO LTD. | F | $545.1M | $3.13 | — | $0.00 | — |
| ZVRA | Zevra Therapeutics, Inc. | B+ | $539.1M | $9.06 | 7.61 | $147.8M | 52.8% |
| RGNX | REGENXBIO Inc. | F- | $505.2M | $7.64 | — | $153.9M | -113.9% |
| GYRE | Gyre Therapeutics, Inc. | F- | $495.9M | $4.30 | — | $108.1M | -33.9% |
| NGNE | Neurogene Inc. | F | $495M | $23.91 | — | $0.00 | — |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | $494.3M | $6.08 | — | $274.9M | -30.2% |
| VALN | Valneva SE | F- | $491.1M | $5.66 | — | $174.7M | -73.7% |
| MNPR | Monopar Therapeutics Inc. | F | $488.4M | $72.07 | — | $0.00 | — |
| CADL | CANDEL THERAPEUTICS, INC. | 評価なし | $486.4M | $6.20 | — | — | — |
| INDP | Indaptus Therapeutics, Inc. | 評価なし | $485.4M | $3.16 | — | — | — |
| DMAC | DIAMEDICA THERAPEUTICS INC. | 評価なし | $475.1M | $8.81 | — | — | — |
| STTK | Shattuck Labs, Inc. | F | $472.5M | $4.64 | — | $0.00 | — |
| MDXG | MIMEDX GROUP, INC. | F | $468.4M | $3.21 | — | $303.7M | -6.3% |
| JSPR | Jasper Therapeutics, Inc. | 評価なし | $454.9M | $13.67 | — | — | — |
| RLMD | RELMADA THERAPEUTICS, INC. | 評価なし | $450.3M | $4.22 | — | — | — |
| AVTX | AVALO THERAPEUTICS, INC. | F- | $448.1M | $7.75 | — | $59K | -150,259.3% |
| BLSM | BlossomHill Therapeutics, Inc. | 評価なし | $447.2M | $14.07 | — | — | — |
| ARVN | ARVINAS, INC. | C- | $446.6M | $6.82 | — | $275.3M | -3.5% |
| CTMX | CytomX Therapeutics, Inc. | F- | $443.6M | $2.04 | — | $14M | -609.0% |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | C- | $433.1M | $21.15 | — | $72.3M | -15.4% |
| IRLA | IRulya Therapeutics Inc. | 評価なし | $431.3M | $39.78 | — | — | — |
| KRSA | Korsana Biosciences, Inc. | F | $426.1M | $31.50 | — | $1.9M | -3,098.7% |
| TECX | TECTONIC THERAPEUTIC, INC. | 評価なし | $419.7M | $21.04 | — | — | — |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | D- | $419.5M | $8.17 | — | $52.7M | -45.4% |
| FENC | FENNEC PHARMACEUTICALS INC. | A | $411.1M | $11.65 | 582.25 | $66.4M | 3.1% |
| OCS | Oculis Holding AG | 評価なし | $401.2M | $7.68 | — | — | — |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | $401.2M | $7.76 | 16.87 | $231.8M | 10.3% |
| SPRY | ARS Pharmaceuticals, Inc. | F- | $392.1M | $3.90 | — | $122.1M | -163.6% |
| IRD | Opus Genetics, Inc. | F- | $385.7M | $3.99 | — | $7.9M | -1,726.7% |
| ALEC | Alector, Inc. | B+ | $379.6M | $2.55 | 7.29 | $173.5M | 23.9% |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | 評価なし | $371.9M | $1.72 | — | — | — |
| CRMD | CORMEDIX INC. | B+ | $370.2M | $4.66 | 7.76 | $412.5M | 15.5% |
| CCCC | C4 Therapeutics, Inc. | D- | $363.1M | $2.77 | — | $32.3M | -282.2% |
| RZLT | Rezolute, Inc. | 評価なし | $353.1M | $3.65 | — | — | — |
| LYEL | Lyell Immunopharma, Inc. | F- | $350.6M | $14.26 | — | $15K | -1,701,066.7% |
| AVIR | Atea Pharmaceuticals, Inc. | 評価なし | $345.3M | $4.30 | — | — | — |
| YDES | YD Bio Limited | D | $345.1M | $4.88 | — | $596.8K | -1,392.6% |
| ANL | Adlai Nortye Ltd. | C | $341.2M | $10.67 | — | $5M | -710.6% |
| EDIT | EDITAS MEDICINE, INC. | B- | $334.1M | $2.17 | — | $49.8M | -145.0% |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | $326M | $8.16 | — | $0.00 | — |
| BNTC | BENITEC BIOPHARMA INC. | D | $325.8M | $9.02 | — | $0.00 | — |
| IMUX | Immunic, Inc. | 評価なし | $323.5M | $7.56 | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | 評価なし | $322.9M | $5.96 | — | — | — |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | $319.8M | $10.98 | — | $65.3M | -96.9% |
| KYTX | Kyverna Therapeutics, Inc. | 評価なし | $319.3M | $5.05 | — | — | — |
| ALT | ALTIMMUNE, INC. | D- | $319.1M | $1.64 | — | $41K | -254,522.0% |
| XFOR | X4 PHARMACEUTICALS, INC | D- | $318.6M | $3.12 | — | $17M | -474.7% |
| EVMN | Evommune, Inc. | F | $315.5M | $7.63 | — | $0.00 | — |
| PROK | ProKidney Corp. | F- | $314.5M | $1.04 | — | $775K | -13,326.7% |
| LRMR | LARIMAR THERAPEUTICS, INC. | 評価なし | $312.7M | $3.01 | — | — | — |
| SCTX | SCRIBE THERAPEUTICS INC. | 評価なし | $310.2M | $16.38 | — | — | — |
| AUTL | AUTOLUS THERAPEUTICS PLC | C- | $309M | $1.16 | — | $137.4M | -186.4% |
| VERU | VERU INC. | 評価なし | $308.9M | $2.11 | — | — | — |
| GALT | GALECTIN THERAPEUTICS INC. | 評価なし | $308.6M | $3.06 | — | — | — |
| HELP | CYBIN INC. | 評価なし | $308M | $8.85 | — | — | — |
| MPLT | MapLight Therapeutics, Inc. | 評価なし | $307.7M | $7.25 | — | — | — |
| AGEN | AGENUS INC | D | $304.1M | $6.72 | 10.18 | $133.9M | 23.0% |
| IPSC | Century Therapeutics, Inc. | C- | $301.5M | $1.66 | — | $109.2M | -90.5% |
| PEPG | PEPGEN INC. | 評価なし | $301.3M | $4.35 | — | — | — |
| NAUT | NAUTILUS BIOTECHNOLOGY, INC. | 評価なし | $295.5M | $2.32 | — | — | — |
| ALLO | Allogene Therapeutics, Inc. | C- | $290.7M | $0.84 | — | $6.9M | -2,513.9% |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | $288M | $3.77 | — | $0.00 | — |
| TTRX | Turn Therapeutics Inc. | 評価なし | $285.9M | $9.35 | — | — | — |
| OCGN | OCUGEN, INC. | F | $280.9M | $0.83 | — | $4.8M | -1,367.6% |
| CABA | CABALETTA BIO, INC. | 評価なし | $276.1M | $1.28 | — | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | $275.7M | $3.46 | — | $22.4M | -269.7% |
| YARW | YARROW BIOSCIENCE, INC. | D | $274.1M | $17.99 | — | $482K | -3,881.5% |
| INO | INOVIO PHARMACEUTICALS, INC. | C- | $268.8M | $1.44 | — | $298.9K | -23,798.9% |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | $267.6M | $2.97 | — | $0.00 | — |
| QTTB | Q32 Bio Inc. | B | $261.4M | $8.74 | 2.52 | $53.7M | 60.0% |
| FTH | Faeth Therapeutics, Inc. | 評価なし | $259.9M | $10.06 | — | — | — |
| PLX | PROTALIX BIOTHERAPEUTICS, INC. | A+ | $257.2M | $3.05 | 12.20 | $84.7M | 24.3% |
| RCKT | Rocket Pharmaceuticals, Inc. | D | $255.1M | $2.29 | — | $0.00 | — |
| VOGX | Vogenx, Inc. | 評価なし | $252.1M | $16.97 | — | — | — |
| CUVL | CLINUVEL PHARMACEUTICALS LIMITED | C+ | $250.6M | $4.97 | 10.80 | $64.3M | 36.0% |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | $241.9M | $4.00 | — | $229.3M | -119.9% |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | $240.4M | $8.34 | — | $30.5M | -285.9% |
| IMRX | Immuneering Corporation | 評価なし | $240.1M | $3.71 | — | — | — |
| CAMP | CAMP4 Therapeutics Corporation | B- | $236.6M | $3.77 | — | $5.3M | -2,276.3% |
| LXEO | Lexeo Therapeutics, Inc. | 評価なし | $235.5M | $2.87 | — | — | — |
| BCYC | Bicycle Therapeutics plc | C- | $234.4M | $3.35 | — | $83.5M | -169.8% |
| LCTX | Lineage Cell Therapeutics, Inc. | F | $229.4M | $0.91 | — | $10.8M | 16.2% |
| CTNM | Contineum Therapeutics, Inc. | 評価なし | $227.8M | $9.86 | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | 評価なし | $227.6M | $14.11 | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | 評価なし | $219.2M | $14.94 | — | — | — |
| ACIU | AC IMMUNE SA | D- | $216.2M | $2.13 | — | $4.5M | -1,903.0% |
| IKT | INHIBIKASE THERAPEUTICS, INC. | F | $213.2M | $1.52 | — | $0.00 | — |
| DTIL | PRECISION BIOSCIENCES INC | D- | $211.3M | $7.57 | — | $45M | -85.6% |
| KROS | KEROS THERAPEUTICS, INC. | F- | $202.7M | $10.33 | — | $40.8M | -151.4% |
| PALI | PALISADE BIO, INC. | F- | $199.9M | $1.12 | — | $500K | -8,739.2% |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | $198.9M | $5.08 | — | $4M | -4,058.0% |
| CGEN | COMPUGEN LTD | B+ | $198.6M | $2.10 | 5.53 | $75.9M | 47.9% |
| ARTV | Artiva Biotherapeutics, Inc. | F- | $198.2M | $4.01 | — | $0.00 | — |
| ALPS | ALPS GROUP INC | 評価なし | $198M | $1.19 | — | — | — |
| LIMN | LIMINATUS PHARMA, INC. | 評価なし | $196.1M | $2.92 | — | — | — |
| RNAC | Cartesian Therapeutics, Inc. | F | $193.7M | $6.35 | — | $1M | -12,435.2% |
| PYXS | Pyxis Oncology, Inc. | D- | $189M | $1.58 | — | $13.9M | -625.7% |
| KRRO | Korro Bio, Inc. | D- | $186.3M | $13.57 | — | $1.3M | -8,214.5% |
| ACOG | Alpha Cognition Inc. | D- | $184.4M | $8.37 | — | $20.2M | -144.6% |
| OVID | Ovid Therapeutics Inc. | D- | $181M | $2.55 | — | $1.5M | -2,971.3% |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | $180.6M | $3.06 | — | $0.00 | — |
| ELDN | ELEDON PHARMACEUTICALS, INC. | 評価なし | $178.2M | $2.11 | — | — | — |
| ANTX | AN2 Therapeutics, Inc. | 評価なし | $173.4M | $4.57 | — | — | — |
| IVVD | INVIVYD, INC. | D- | $171.8M | $0.58 | — | $58.4M | -183.9% |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | 評価なし | $171.3M | $2.14 | — | — | — |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | $167.1M | $1.70 | — | $0.00 | — |
| MDWD | MEDIWOUND LTD. | F- | $165.3M | $12.88 | — | $10M | -235.0% |
| STRO | SUTRO BIOPHARMA, INC. | D | $163.2M | $9.83 | — | $45.1M | -344.2% |
| GTBP | GT Biopharma, Inc. | 評価なし | $162.8M | $3.61 | 9.75 | — | — |
| RNA | Atrium Therapeutics, Inc. | 評価なし | $162M | $7.51 | — | — | — |
| ENGN | enGene Therapeutics Inc. | 評価なし | $161.5M | $2.41 | — | — | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | $160.9M | $3.70 | — | $2M | 7,244.3% |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | 評価なし | $159.2M | $23.15 | — | — | — |
| SLGL | Sol-Gel Technologies Ltd. | D | $156M | $56.01 | — | $1.4M | -426.7% |
| TARA | Protara Therapeutics, Inc. | 評価なし | $155.5M | $2.53 | — | — | — |
| FATE | FATE THERAPEUTICS INC | F- | $155M | $1.28 | — | $4.8M | -2,619.6% |
| HUMA | Humacyte, Inc. | C- | $154M | $0.55 | — | $2.4M | -3,955.1% |
| UPB | UPSTREAM BIO, INC. | F- | $151.3M | $2.76 | — | $2.9M | -5,712.3% |
| SION | SIONNA THERAPEUTICS, INC. | 評価なし | $150.6M | $3.33 | — | — | — |
| NGEN | NERVGEN PHARMA CORP. | 評価なし | $149.7M | $1.88 | — | — | — |
| PRQR | ProQR Therapeutics N.V. | C- | $147.5M | $1.40 | — | $22.8M | -204.4% |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 評価なし | $143.1M | $1.04 | — | — | — |
| ARMP | ARMATA PHARMACEUTICALS, INC. | 評価なし | $142.8M | $3.84 | — | — | — |
| MGNX | MACROGENICS, INC. | D- | $141.9M | $2.22 | — | $154.9M | -33.2% |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | $141.7M | $4.91 | — | $40K | -107,587.6% |
| CMPX | COMPASS THERAPEUTICS, INC. | F | $139.2M | $0.77 | — | $0.00 | — |
| ABEO | ABEONA THERAPEUTICS INC. | C- | $137.7M | $2.41 | — | $39M | -160.3% |
| MENS | Jyong Biotech Ltd. | 評価なし | $132.3M | $1.74 | — | — | — |
| IPHA | Innate Pharma SA | F- | $130.3M | $1.39 | — | $10.1M | -546.1% |
| LENZ | LENZ THERAPEUTICS, INC. | F- | $129.8M | $4.13 | — | $12.4M | -1,135.0% |
| CDXS | Codexis, Inc. | B- | $124.4M | $1.14 | — | $88.3M | -21.8% |
| SPRB | Spruce Biosciences, Inc. | F | $123.9M | $43.12 | — | $0.00 | — |
| FHTX | Foghorn Therapeutics Inc. | B | $123.8M | $2.07 | 29.50 | $112.1M | 8.4% |
| CLLS | Cellectis S.A. | F- | $119.8M | $1.20 | — | $25.2M | -506.1% |
| ZURA | Zura Bio Limited | 評価なし | $119.4M | $1.24 | — | — | — |
| CUE | Cue Biopharma, Inc. | D- | $117.4M | $16.16 | — | $37.7M | -435.8% |
| NERV | Minerva Neurosciences, Inc. | 評価なし | $115.1M | $2.31 | — | — | — |
| PYPD | PolyPid Ltd | 評価なし | $114.5M | $6.29 | — | — | — |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | $110.1M | $4.44 | — | $194K | -3,985.6% |
| IBIO | iBio, Inc. | C- | $110M | $0.73 | — | $1.1M | -3,244.2% |
| VYGR | Voyager Therapeutics, Inc. | F- | $107.3M | $1.73 | — | $25.1M | -416.3% |
| OKUR | ONKURE THERAPEUTICS, INC. | 評価なし | $106.3M | $2.63 | — | — | — |
| EQ | Equillium, Inc. | 評価なし | $106.2M | $1.29 | — | — | — |
| MSLE | Satellos Bioscience Inc. | 評価なし | $102.5M | $6.63 | — | — | — |
| ADAG | Adagene Inc. | C- | $101M | $1.71 | — | $7.7M | -229.6% |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | $100.6M | $0.41 | — | -$1.2M | 5,253.5% |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | 評価なし | $98.9M | $3.55 | — | — | — |
| ICCC | ImmuCell Corporation | A | $97.6M | $10.74 | 56.53 | $33.2M | 5.7% |
| NBP | NovaBridge Biosciences | 評価なし | $96.3M | $0.83 | — | — | — |
| PMVP | PMV PHARMACEUTICALS, INC. | 評価なし | $95.6M | $1.27 | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | $92.1M | $1.40 | — | $0.00 | — |
| ANIX | ANIXA BIOSCIENCES, INC. | 評価なし | $91.6M | $2.64 | — | — | — |
| VANI | Vivani Medical, Inc. | F | $91.6M | $1.02 | — | $0.00 | — |
| PLYX | Polaryx Therapeutics, Inc. | 評価なし | $91.5M | $1.84 | — | — | — |
| SEER | SEER, INC. | F- | $87.6M | $1.57 | — | $14.1M | -450.9% |
| AVXL | ANAVEX LIFE SCIENCES CORP. | 評価なし | $86.5M | $0.93 | — | — | — |
| CBUS | Cibus, Inc. | C- | $86.2M | $1.13 | — | $4.5M | -2,131.4% |
| NKTX | Nkarta, Inc. | D | $85.3M | $1.19 | — | $0.00 | — |
| GNLX | GENELUX CORPORATION | F- | $85.1M | $1.88 | — | $8K | -444,950.0% |
| RLYB | RALLYBIO CORPORATION | A | $84.9M | $15.76 | — | $434K | 6,177.4% |
| IFRX | InflaRx N.V. | F- | $84.6M | $1.17 | — | $32.8K | -155,582.1% |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | F | $83.9M | $1.46 | — | $0.00 | — |
| LONA | LeonaBio, Inc. | 評価なし | $82.3M | $3.47 | — | — | — |
| CHRS | Coherus Oncology, Inc. | C | $80.7M | $0.52 | — | $53.6M | -253.4% |
| NMRA | NEUMORA THERAPEUTICS, INC. | 評価なし | $80.6M | $0.43 | — | — | — |
| ATRA | Atara Biotherapeutics, Inc. | F | $80.5M | $7.90 | — | $4M | -368.6% |
| TNYA | TENAYA THERAPEUTICS, INC. | 評価なし | $79.1M | $0.35 | — | — | — |
| NRXS | NEURAXIS, INC. | D- | $78M | $5.50 | — | $6.5M | -185.2% |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | $73.8M | $0.53 | — | $6.6M | -493.0% |
| TENX | TENAX THERAPEUTICS, INC. | F | $73.8M | $1.62 | — | $0.00 | — |
| COYA | Coya Therapeutics, Inc. | F- | $73.2M | $3.12 | — | $4.7M | -643.5% |
| NTRB | NUTRIBAND INC. | F- | $72.3M | $5.95 | — | $1.6M | -430.4% |
| PMCB | PHARMACYTE BIOTECH, INC. | D | $71.7M | $6.68 | — | $0.00 | — |
| MNOV | MEDICINOVA, INC. | D- | $71.2M | $1.39 | — | $935.7K | -1,127.0% |
| OKYO | OKYO Pharma Limited | 評価なし | $69.8M | $1.33 | — | — | — |
| FBIO | Fortress Biotech, Inc. | B | $69.7M | $1.88 | — | $70M | 143.0% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 評価なし | $69.7M | $3.38 | — | — | — |
| JAGX | Jaguar Health, Inc. | C | $69.4M | $0.40 | — | $27.8M | -132.2% |
| TLSA | Tiziana Life Sciences Ltd | 評価なし | $68.1M | $0.57 | — | — | — |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | $67.9M | $4.88 | — | $60.7M | -1.8% |
| GOSS | GOSSAMER BIO, INC. | B | $67M | $10.95 | — | $78.4M | -159.5% |
| CING | Cingulate Inc. | 評価なし | $64.9M | $4.34 | — | — | — |
| MIST | Milestone Pharmaceuticals Inc. | 評価なし | $64.8M | $0.52 | — | — | — |
| CGTX | Cognition Therapeutics, Inc. | 評価なし | $63.8M | $0.67 | — | — | — |
| ACRV | Acrivon Therapeutics, Inc. | 評価なし | $62.1M | $1.45 | — | — | — |
| MAIA | MAIA BIOTECHNOLOGY, INC. | 評価なし | $61.8M | $1.00 | — | — | — |
| ETRA | Electra Therapeutics, Inc. | 評価なし | $61.7M | $8.96 | — | — | — |
| VRCA | Verrica Pharmaceuticals Inc. | D- | $61.5M | $3.58 | — | $22.9M | -189.2% |
| CNXU | CONEXEU SCIENCES INC. | 評価なし | $61.5M | $2.18 | — | — | — |
| XBIT | XBIOTECH INC. | 評価なし | $59.5M | $1.95 | — | — | — |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | D- | $59.3M | $0.31 | — | $148.2M | -14.5% |
| BOLD | BOUNDLESS BIO, INC. | 評価なし | $59M | $2.50 | — | — | — |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | $58.5M | $3.01 | — | $43M | -420.4% |
| CLGN | CollPlant Biotechnologies Ltd | D- | $58.4M | $4.56 | — | $318K | -4,130.2% |
| SPRO | SPERO THERAPEUTICS, INC. | F- | $57.8M | $0.99 | — | $41.6M | -71.0% |
| XLO | Xilio Therapeutics, Inc. | D- | $57.6M | $8.16 | — | $55M | -20.9% |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | $56.6M | $0.73 | — | $559K | -6,735.2% |
| ANVS | Annovis Bio, Inc. | F | $56.4M | $0.91 | — | $0.00 | — |
| CLNN | Clene Inc. | C | $56.3M | $3.91 | — | $238K | -11,271.4% |
| AZR | Azora Therapeutics, Inc. (DE) | 評価なし | $56.1M | $3.93 | — | — | — |
| NRSN | NeuroSense Therapeutics Ltd. | 評価なし | $53.1M | $1.63 | — | — | — |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | $51.9M | $12.87 | 1.53 | $0.00 | — |
| ATNM | Actinium Pharmaceuticals, Inc. | D+ | $51.6M | $1.64 | 4.56 | $90K | 12,564.4% |
| RNXT | RENOVORX, INC. | D- | $50.4M | $1.05 | — | $2.8M | -469.0% |
| ONCY | ONCOLYTICS BIOTECH INC. | 評価なし | $50.2M | $0.37 | — | — | — |
| MREO | MEREO BIOPHARMA GROUP PLC | C | $49M | $0.31 | — | $500K | -5,387.6% |
| PDSB | PDS Biotechnology Corporation | 評価なし | $48.5M | $0.87 | — | — | — |
| INKT | MiNK Therapeutics, Inc. | 評価なし | $48.3M | $9.41 | — | — | — |
| HYFT | MindWalk Holdings Corp. | C- | $48.1M | $1.03 | — | $20.1M | -43.6% |
| HOWL | WEREWOLF THERAPEUTICS, INC. | 評価なし | $47.6M | $0.98 | — | — | — |
| RNTX | Rein Therapeutics, Inc. | F | $46.9M | $0.54 | — | $0.00 | — |
| GANX | GAIN THERAPEUTICS, INC | 評価なし | $46.3M | $1.04 | — | — | — |
| DWTX | Dogwood Therapeutics, Inc. | 評価なし | $44.3M | $1.16 | — | — | — |
| IBO | Impact BioMedical, INC. | A | $44.2M | $5.11 | — | $38K | 4,247.4% |
| PLRX | PLIANT THERAPEUTICS, INC. | D | $43.2M | $0.70 | — | $0.00 | — |
| IMA | ImageneBio, Inc. | C- | $43.1M | $3.46 | — | $800K | -5,415.6% |
| CNTB | Connect Biopharma Holdings Limited | C- | $42.6M | $0.68 | — | $3M | -2,336.3% |
| BMEA | Biomea Fusion, Inc. | 評価なし | $42.3M | $0.58 | — | — | — |
| ELTX | Elicio Therapeutics, Inc. | 評価なし | $42.2M | $1.49 | — | — | — |
| TIL | Instil Bio, Inc. | C- | $41M | $6.05 | — | $9M | -337.7% |
| HYPD | HYPERION DEFI, INC. | B+ | $40.1M | $2.59 | — | $1.9M | 2,075.4% |
| SER | Serina Therapeutics, Inc. | D | $39.9M | $1.50 | — | $260K | -9,421.5% |
| ALDX | ALDEYRA THERAPEUTICS, INC. | 評価なし | $39.3M | $0.65 | — | — | — |
| CRBU | Caribou Biosciences, Inc. | F- | $39.2M | $0.36 | — | $9.4M | -1,085.0% |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | $38.5M | $1.51 | — | $357.9K | -3,089.6% |
| TVGN | Tevogen Inc. | 評価なし | $38.4M | $5.90 | — | — | — |
| GRCE | Grace Therapeutics, Inc. | 評価なし | $38M | $1.81 | — | — | — |
| KLRS | KALARIS THERAPEUTICS, INC. | 評価なし | $37.5M | $1.58 | — | — | — |
| EXOZ | EXOZYMES INC. | 評価なし | $36.8M | $3.90 | — | — | — |
| TELO | Telomir Pharmaceuticals, Inc. | 評価なし | $36.2M | $0.49 | — | — | — |
| OSTX | OS THERAPIES INCORPORATED | 評価なし | $34.4M | $0.75 | — | — | — |
| INMB | INMUNE BIO INC. | D- | $32.5M | $1.05 | — | $50K | -33,332.0% |
| NNVC | NANOVIRICIDES, INC. | F | $31.5M | $1.24 | — | $0.00 | — |
| PMN | PROMIS NEUROSCIENCES INC. | 評価なし | $29.6M | $3.29 | — | — | — |
| BCTX | BRIACELL THERAPEUTICS CORP. | 評価なし | $29.3M | $3.35 | — | — | — |
| AARD | AARDVARK THERAPEUTICS, INC. | F | $29.1M | $1.33 | — | $0.00 | — |
| PTHS | Pelthos Therapeutics Inc. | D- | $28.6M | $7.29 | — | $51.3M | -152.2% |
| NXTC | NextCure, Inc. | 評価なし | $28.6M | $6.24 | — | — | — |
| IMMP | Immutep Limited | D- | $26.9M | $3.65 | — | $7.3M | -594.6% |
| GRDX | GridAI Technologies Corp. | F- | $26.7M | $3.74 | — | $36.3K | -56,864.0% |
| MGX | Metagenomi Therapeutics, Inc. | F- | $26.4M | $0.70 | — | $22.3M | -421.8% |
| ALGS | Aligos Therapeutics, Inc. | F- | $26.3M | $2.11 | — | $5.8M | -1,137.2% |
| ACET | Adicet Bio, Inc. | 評価なし | $25.8M | $2.76 | — | — | — |
| CRVO | CervoMed Inc. | F- | $25.3M | $1.68 | — | $8.7K | -326,822.5% |
| BYSI | BeyondSpring Inc. | D | $25.2M | $0.61 | — | $0.00 | — |
| LITS | Lite Strategy, Inc. | D | $25.1M | $0.84 | — | $0.00 | — |
| ABVC | ABVC BioPharma, Inc. | D- | $24.5M | $0.91 | — | $296K | -1,322.6% |
| APRE | Aprea Therapeutics, Inc. | 評価なし | $23.9M | $0.44 | — | — | — |
| ENLV | Enlivex Ltd. | 評価なし | $22.8M | $1.18 | 0.01 | — | — |
| EVAX | Evaxion A/S | B- | $22.8M | $2.74 | — | $7.5M | -102.4% |
| CVM | CEL-SCI CORPORATION | 評価なし | $22.3M | $1.27 | — | — | — |
| FLNA | Filana Therapeutics, Inc. | 評価なし | $21.4M | $0.43 | — | — | — |
| ATHE | ALTERITY THERAPEUTICS LTD | 評価なし | $21.2M | $1.99 | — | — | — |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | 評価なし | $20.9M | $0.48 | — | — | — |
| IGC | IGC PHARMA, INC. | C- | $20.7M | $0.18 | — | $1.3M | -560.3% |
| CNSP | CNS Pharmaceuticals, Inc. | 評価なし | $20.4M | $2.98 | — | — | — |
| CELU | Celularity Inc. | D | $20.2M | $0.62 | — | $18.7M | -245.7% |
| BSEM | BioStem Technologies, Inc. | 評価なし | $20.1M | $1.05 | — | $47.5M | -13.9% |
| APLM | Apollomics Inc. | B | $19.9M | $18.01 | — | $8.5M | -128.7% |
| ATOS | ATOSSA THERAPEUTICS, INC. | 評価なし | $19.4M | $1.95 | — | — | — |
| NRXP | NRX Pharmaceuticals, Inc. | B | $19.4M | $2.19 | — | $3.4M | -691.8% |
| COCP | COCRYSTAL PHARMA, INC. | 評価なし | $19.4M | $1.01 | — | — | — |
| LPCN | LIPOCINE INC. | D- | $19M | $1.72 | — | $3.7M | -249.2% |
| KTTA | PASITHEA THERAPEUTICS CORP. | 評価なし | $19M | $0.52 | — | — | — |
| EDSA | EDESA BIOTECH, INC. | 評価なし | $18.7M | $1.94 | — | — | — |
| PLUR | Pluri Inc. | B | $17.3M | $1.20 | — | $1.5M | -1,943.9% |
| CNTX | CONTEXT THERAPEUTICS INC. | 評価なし | $17.1M | $0.19 | — | — | — |
| BOLT | Bolt Biotherapeutics, Inc. | F- | $15.9M | $6.09 | — | $2.5M | -1,034.4% |
| TVRD | TVARDI THERAPEUTICS, INC. | F- | $15.8M | $1.18 | — | $7.6M | -352.1% |
| ATYR | ATYR PHARMA, INC. | F- | $15.6M | $6.11 | — | $190K | -28,065.3% |
| ALLR | Allarity Therapeutics, Inc. | C- | $15.5M | $0.97 | — | $350K | -4,493.7% |
| ABOS | Acumen Pharmaceuticals, Inc. | 評価なし | $15.4M | $0.21 | — | — | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | $15M | $0.90 | — | $3.9M | -220.5% |
| CTXR | Citius Pharmaceuticals, Inc. | 評価なし | $14.7M | $0.54 | — | — | — |
| KYNB | KYNTRA BIO, INC. | F | $14.6M | $3.60 | — | $4.6M | 3,967.8% |
| MCRB | Seres Therapeutics, Inc. | D- | $14.2M | $1.39 | — | $2.1M | -2,209.6% |
| LSTA | LISATA THERAPEUTICS, INC. | F- | $13.5M | $1.25 | — | $100K | -17,159.0% |
| PASG | Passage BIO, Inc. | 評価なし | $13.4M | $4.16 | — | — | — |
| DYAI | DYADIC INTERNATIONAL, INC. | D- | $13.3M | $0.33 | — | $3.1M | -226.9% |
| BCDA | BioCardia, Inc. | F | $13M | $0.86 | — | $0.00 | — |
| ONCO | Onconetix, Inc. | F- | $12.6M | $3.20 | — | $645.8K | -1,578.8% |
| NIKI | Niki BioSolutions, Inc. | 評価なし | $12.5M | $1.71 | — | — | — |
| NCEL | NewcelX Ltd. | 評価なし | $12.5M | $2.60 | — | — | — |
| BIVI | BIOVIE INC. | 評価なし | $12.2M | $1.14 | — | — | — |
| GUTS | Fractyl Health, Inc. | F- | $12M | $0.91 | — | $0.00 | — |
| CLRB | Cellectar Biosciences, Inc. | 評価なし | $11.4M | $1.14 | — | — | — |
| PTN | PALATIN TECHNOLOGIES, INC. | B- | $11.2M | $6.29 | — | $13.2M | -63.6% |
| HIND | VYOME HOLDINGS, INC. | D- | $11.2M | $1.59 | — | $153.1K | -2,455.6% |
| CMMB | SNOWDRIFT PARENT CORPORATION | 評価なし | $11.1M | $1.54 | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | $10.9M | $0.16 | — | $5.2M | -2,219.2% |
| KZIA | Kazia Therapeutics Limited. | F | $10.7M | $6.62 | 5.83 | $29.5K | -54,287.3% |
| INTS | INTENSITY THERAPEUTICS, INC. | 評価なし | $10M | $3.03 | — | — | — |
| DARE | Dare Bioscience, Inc. | C- | $9.9M | $0.65 | — | $1.4M | -804.4% |
| GDTC | CytoMed Therapeutics Limited | D- | $9.6M | $0.81 | — | $253.7K | -1,227.1% |
| ICU | SeaStar Medical Holding Corp | D- | $9.3M | $0.82 | — | $2.2M | -678.2% |
| CNSY | CERENOME, INC. | F- | $9.2M | $0.94 | — | $3.5M | -859.5% |
| INAB | IN8BIO, INC. | 評価なし | $9M | $0.84 | — | — | — |
| RADX | Radiopharm Theranostics Limited | F- | $8.9M | $0.75 | — | $3.6M | -1,055.3% |
| MTVA | METAVIA INC. | 評価なし | $8.7M | $1.29 | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | $8.7M | $8.16 | — | $0.00 | — |
| CALC | CalciMedica, Inc. | 評価なし | $8.3M | $1.21 | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | $8.3M | $0.18 | — | $2.4M | -2,474.5% |
| ENSC | ENSYSCE BIOSCIENCES, INC. | F- | $8.1M | $0.42 | — | $6.2M | -1,470.4% |
| AEON | AEON Biopharma, Inc. | 評価なし | $7.8M | $0.16 | — | — | — |
| CURX | Curanex Pharmaceuticals Inc | 評価なし | $7.5M | $4.79 | — | — | — |
| SNGX | SOLIGENIX, INC. | 評価なし | $7.5M | $0.32 | — | — | — |
| TPST | Tempest Therapeutics, Inc. | 評価なし | $7.4M | $0.37 | — | — | — |
| ACTU | Actuate Therapeutics, Inc. | 評価なし | $7M | $0.29 | — | — | — |
| IMRN | IMMURON LIMITED | D- | $6.9M | $0.86 | — | $5.1M | -71.6% |
| ENVB | ENVERIC BIOSCIENCES, INC. | 評価なし | $6.8M | $1.51 | — | — | — |
| TOVX | THERIVA BIOLOGICS, INC. | 評価なし | $6.6M | $0.14 | — | — | — |
| XCUR | EXICURE, INC. | F | $6.5M | $1.00 | — | $0.00 | — |
| FBLG | FibroBiologics, Inc. | 評価なし | $6.4M | $0.97 | — | — | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | B- | $6.2M | $2.09 | — | $15.2K | -42,721.9% |
| ALZN | ALZAMEND NEURO, INC. | 評価なし | $6M | $1.25 | — | — | — |
| AIM | AIM IMMUNOTECH INC. | F | $5.8M | $0.14 | — | $91K | -15,526.4% |
| ACXP | Acurx Pharmaceuticals, Inc. | 評価なし | $5.8M | $0.95 | — | — | — |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | 評価なし | $5.6M | $0.88 | — | — | — |
| BLRX | BioLineRx Ltd | C- | $5.6M | $1.28 | — | $1.4M | -145.5% |
| LTRN | LANTERN PHARMA INC. | 評価なし | $5.5M | $0.43 | — | — | — |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | $5.5M | $1.24 | — | $0.00 | — |
| CVKD | Cadrenal Therapeutics, Inc. | 評価なし | $5.4M | $1.51 | — | — | — |
| PCSA | Processa Pharmaceuticals, Inc. | 評価なし | $5.3M | $1.90 | — | — | — |
| CMND | Clearmind Medicine Inc. | 評価なし | $5.2M | $4.46 | — | — | — |
| SKYE | Skye Bioscience, Inc. | 評価なし | $5M | $1.14 | — | — | — |
| ADXN | Addex Therapeutics Ltd | D- | $4.9M | $3.98 | — | $36.4K | -22,448.4% |
| PULM | Pulmatrix, Inc. | C- | $4.6M | $1.26 | — | $7.8M | -51.4% |
| SNTI | Senti Biosciences Holdings, Inc. | F- | $4.4M | $0.14 | — | $55K | -90,116.4% |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | $4.2M | $1.77 | — | $451K | -1,545.2% |
| TCRT | Alaunos Therapeutics, Inc. | D- | $4.1M | $1.63 | — | $3K | -133,666.7% |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | D- | $4M | $0.53 | — | $3K | -249,160.1% |
| XBIO | XENETIC BIOSCIENCES, INC. | F- | $4M | $1.71 | — | $3M | -123.7% |
| TRAW | Traws Pharma, Inc. | D- | $4M | $0.26 | — | $2.8M | -773.0% |
| GRI | GRI Bio, Inc. | 評価なし | $4M | $1.82 | — | — | — |
| SILO | SILO PHARMA, INC. | D- | $3.9M | $1.83 | — | $36.1K | -10,319.0% |
| AZTR | Azitra, Inc. | F- | $3.8M | $0.62 | — | $0.00 | — |
| IMNN | Imunon, Inc. | 評価なし | $3.7M | $0.58 | — | — | — |
| PHIO | Phio Pharmaceuticals Corp | 評価なし | $3.7M | $0.77 | — | — | — |
| AGMB | AgomAb Therapeutics NV | 評価なし | $3.4M | $6.27 | — | — | — |
| MBIO | MUSTANG BIO, INC. | 評価なし | $3.4M | $0.45 | — | — | — |
| ERNA | Ernexa Therapeutics Inc. | 評価なし | $3.1M | $1.85 | — | — | — |
| EVGN | EVOGENE LTD. | F | $3.1M | $0.36 | — | $1.3M | -551.3% |
| REVB | REVELATION BIOSCIENCES, INC. | 評価なし | $2.9M | $4.28 | — | — | — |
| DRMA | DERMATA THERAPEUTICS, INC. | 評価なし | $2.9M | $0.59 | — | — | — |
| GNPX | Genprex, Inc. | 評価なし | $2.8M | $2.09 | — | — | — |
| VIVS | VivoSim Labs, Inc. | C | $2.5M | $0.13 | — | $135K | -7,605.9% |
| VRAX | Virax Biolabs Group Ltd | C- | $2.3M | $0.63 | — | $6.3K | -95,739.2% |
| CLDI | Calidi Biotherapeutics, Inc. | 評価なし | $2.2M | $0.63 | — | — | — |
| KAPA | KAIROS PHARMA, LTD. | 評価なし | $2.2M | $0.46 | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | 評価なし | $2M | $1.95 | — | — | — |
| ARTL | ARTELO BIOSCIENCES, INC. | 評価なし | $2M | $2.18 | — | — | — |
| ELAB | PMGC HOLDINGS INC. | D- | $1.9M | $1.63 | — | $4.8M | -275.7% |
| CRIS | CURIS INC | F- | $1.9M | $0.44 | — | $4.3M | -499.4% |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | $1.8M | $0.50 | — | $1.1M | -729.9% |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | $1.8M | $2.28 | — | $21.8K | -42,206.9% |
| PBM | PSYENCE BIOMEDICAL LTD | 評価なし | $1.7M | $3.16 | — | — | — |
| HCWB | HCW Biologics Inc. | B- | $1.6M | $0.86 | — | $6.7M | -83.8% |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | $1.4M | $0.41 | — | $3.1M | -270.9% |
| BDRX | Biodexa Pharmaceuticals PLC | 評価なし | $1.3M | $2.39 | — | — | — |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | 評価なし | $1.3M | $1.32 | — | — | — |
| CANF | Can-Fite BioPharma Ltd. | F- | $1.2M | $1.46 | — | $405K | -2,426.7% |
| BBLG | Bone Biologics Corporation | 評価なし | $1.1M | $0.33 | — | — | — |
| APVO | Aptevo Therapeutics Inc. | 評価なし | $1.1M | $0.59 | — | — | — |
| GOVX | GEOVAX LABS, INC. | D | $928.3K | $1.71 | — | $0.00 | — |
| OGEN | ORAGENICS, INC. | 評価なし | $906.9K | $0.20 | — | — | — |
| DCOY | Decoy Therapeutics Inc. | 評価なし | $811.6K | $0.96 | — | — | — |
| HLSQ | BiomX Inc. | 評価なし | $739.4K | $0.07 | — | — | — |
| QNRX | Quoin Pharmaceuticals, Ltd. | 評価なし | $669.6K | $3.81 | — | — | — |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | 評価なし | $658.5K | $0.28 | — | — | — |
| EDVA | Endovia Health Sciences, Inc. | D | $542.2K | $0.18 | — | $32.1K | -53,856.5% |
| PLRZ | Polyrizon Ltd. | 評価なし | $508.2K | $11.21 | 2.29 | — | — |
| VBIO | Valion Bio, Inc. | F- | $461.2K | $0.52 | — | $482K | -3,890.0% |
| SRZN | Surrozen, Inc./DE | D | $370.9K | $31.50 | — | $10.5M | -3,706.4% |
| SLXN | SILEXION THERAPEUTICS CORP | 評価なし | $363.4K | $1.97 | — | — | — |
| LGVN | LONGEVERON INC. | F- | $339.1K | $2.45 | — | $1.2M | -1,921.7% |
| CDT | CDT EQUITY INC. | 評価なし | $307.4K | $0.39 | — | — | — |
| SPRC | SCISPARC LTD. | F- | $132.6K | $0.36 | — | $679K | -1,793.7% |
| NEUP | Neuphoria Therapeutics Inc. | F- | $76.2K | $2.54 | — | $1.2M | -1,145.7% |
| EYPT | EyePoint, Inc. | F- | $27.6K | $0.31 | — | $2.6M | -13,281.2% |
| KALA | KALA BIO, INC. | F | $10.1K | $0.14 | — | $0.00 | — |
| KPTI | Karyopharm Therapeutics Inc. | C | $503.52 | $0.02 | — | $146.6M | -153.3% |
| PPBT | PURPLE BIOTECH LTD. | 評価なし | $370.84 | $1.55 | — | — | — |
| QNTM | Quantum BioPharma Ltd. | 評価なし | $19.50 | $1.63 | — | — | — |
| APGE | Apogee Therapeutics, Inc. | 評価なし | — | $135.07 | — | — | — |
| ATAI | AtaiBeckley Inc. | 評価なし | — | $7.35 | — | $4.1M | -16,142.0% |
| BCAB | BIOATLA, INC. | 評価なし | — | $1.74 | — | — | — |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | $0.74 | — | $0.00 | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | $84.95 | — | $42.2M | -1,189.9% |
| FBRX | FORTE BIOSCIENCES, INC. | 評価なし | — | $76.99 | — | — | — |
| LNAI | LUNAI BIOWORKS INC. | B | — | $0.16 | — | $52K | -6,852.0% |
| MLEC | MOOLEC SCIENCE SA | B | — | $0.85 | — | $333.6M | -52.9% |
| MOLN | MOLECULAR PARTNERS AG | F | — | $3.22 | — | $0.00 | — |
| OSRH | OSR HEALTH, INC. | D- | — | $0.12 | — | $1.7M | -781.5% |
| SLBT | SL Science Holding Ltd | 評価なし | — | $0.75 | — | — | — |
| TBPH | Theravance Biopharma, Inc. | C | — | $17.03 | — | $104.3M | 51.6% |
| VCRE | Vicore Pharma Holding AB | 評価なし | — | $10.63 | — | — | — |
| VRXA | Veraxa Biotech Holding AG | 評価なし | — | $1.12 | — | — | — |
| VTVT | vTv Therapeutics Inc. | C- | — | $19.52 | — | $36.8M | -20.8% |
ファンダメンタルズは SEC 提出書類から、株価は直近の市場データ取得から。任意の列で並べ替えられます。数値がない企業はどちらの向きでも末尾になります。
時価総額の大きい順です。列をクリックすると並べ替えられます。数値がない企業はどちらの向きでも末尾になります。PER の欠落は割安ではなく赤字を意味するからです。ここに推奨は一切ありません。